Back to Search
DONALD CHARPENTIER, PHARM.D.
PHARM.D.
Pharmacist
NPI: 1336126994Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
2001023387(MO)
Research & Publications (18)
Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein E.
PMID 11123936·Biochemistry·2000
8-other
Concurrent chemoradiation with carboplatin-5-fluorouracil versus cisplatin in locally advanced oropharyngeal cancers: is more always better?
PMID 19427745·Int J Radiat Oncol Biol Phys·2010
4-observational
Organ preservation with concurrent chemoradiation for advanced laryngeal cancer: are we succeeding?
PMID 19394155·Int J Radiat Oncol Biol Phys·2010
8-other
Health-related quality of life in patients with advanced colorectal cancer treated with cetuximab: overall and KRAS-specific results of the NCIC CTG and AGITG CO.17 Trial.
PMID 19273701·J Clin Oncol·2009
2-rct
Treatment results of carcinoma in situ of the glottic larynx: 61 patients treated with radiotherapy.
PMID 19128595·J Otolaryngol Head Neck Surg·2008
8-other
Neck dissection following concurrent chemoradiation for advanced head and neck carcinoma: pathologic findings and complications.
PMID 19128575·J Otolaryngol Head Neck Surg·2008
8-other
Phase II multicenter trial with carboplatin and gemcitabine induction chemotherapy followed by radiotherapy concomitantly with low-dose paclitaxel and gemcitabine for stage IIIA and IIIB non-small cell lung cancer.
PMID 17909355·J Thorac Oncol·2007
3-trial
Primary radiotherapy for tonsillar carcinoma: a good alternative to a surgical approach.
PMID 17176797·J Otolaryngol·2006
8-other
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
PMID 16966366·Ann Oncol·2006
3-trial
Role of neck dissection following concurrent chemoradiation for advanced head and neck carcinoma.
PMID 16933313·Head Neck·2006
8-other
Temozolomide in metastatic breast cancer (MBC): a phase II trial of the National Cancer Institute of Canada - Clinical Trials Group (NCIC-CTG).
PMID 16565212·Ann Oncol·2006
3-trial
A phase I study of T900607 given once every 3 weeks in patients with advanced refractory cancers; National Cancer Institute of Canada Clinical Trials Group (NCIC-CTG) IND 130.
PMID 16133796·Invest New Drugs·2005
3-trial
Retromolar trigone carcinoma treated by primary radiation therapy: an alternative to the primary surgical approach.
PMID 16027279·Arch Otolaryngol Head Neck Surg·2005
4-observational
Phase I study of Tomudex and Doxorubicin in patients with locally advanced, inoperable or metastatic cancer (IND.98).
PMID 15528980·Invest New Drugs·2005
3-trial
The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.
PMID 12809509·Biochemistry·2003
7-preclinical
Weekly paclitaxel and gemcitabine chemotherapy for metastatic non-small cell lung carcinoma (NSCLC): a dose-optimizing phase II trial.
PMID 12712478·Cancer·2003
3-trial
A phase II study of the MDR inhibitor biricodar (INCEL, VX-710) and paclitaxel in women with advanced ovarian cancer refractory to paclitaxel therapy.
PMID 12217752·Gynecol Oncol·2002
3-trial
Neurological manifestations of Behçet's disease in a Caribbean population: clinical and imaging findings.
PMID 11967645·J Neurol·2002
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2625 N KANSAS EXPY
SPRINGFIELD, MO 65803 - Phone
- (417) 869-9003
Quick Facts
- NPI
- 1336126994
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 18
Are you this provider?
Claim Your Profile